Himalaya Nutravedics India IPO (BSE SME)
₹127,200 /1200 shares
Minimum Investment
Himalaya Nutravedics India IPO (BSE SME) Details
Min. Investment
₹127,200
Lot Size
1200
Price Range
₹100 to ₹106
Issue Size
₹26 Cr
About Himalaya Nutravedics India Ltd.
Incorporated in June 2022, Himalaya Nutravedics India Limited is a Hyderabad-based Ayurvedic and nutraceutical manufacturing company engaged in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products including Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
- DRHP View
Strengths & Financials of Himalaya Nutravedics India Ltd.
Stallion India Fluorochemicals operates four facilities located in Khalapur (Maharashtra), Ghiloth (Rajasthan), Manesar (Haryana), and Panvel (Maharashtra). The company states that these facilities are specifically designed and equipped to store gases under controlled conditions and are located near customers.- The company serves a wide range of industries, including air conditioning and refrigeration, fire safety, semiconductor manufacturing, automobile production, pharmaceuticals, medical applications, glass bottle production, aerosols, and spray foam. Stallion India Fluorochemicals states that this diverse client base showcases the demand for the company’s products across various sectors.
- The company is ISO 9001:2015 certified for quality management systems for its compliance in the filling and sale of compressed refrigerant gases.
- The company has seen a consistent increase in revenue from operations. Revenue from operations increased from Rs 185.88 crore in FY22 to Rs 225.50 crore in FY23 to Rs 233.23 crore in FY24.
Stallion India Fluorochemicals operates four facilities located in Khalapur (Maharashtra), Ghiloth (Rajasthan), Manesar (Haryana), and Panvel (Maharashtra). The company states that these facilities are specifically designed and equipped to store gases under controlled conditions and are located near customers.- The company serves a wide range of industries, including air conditioning and refrigeration, fire safety, semiconductor manufacturing, automobile production, pharmaceuticals, medical applications, glass bottle production, aerosols, and spray foam. Stallion India Fluorochemicals states that this diverse client base showcases the demand for the company’s products across various sectors.
- The company is ISO 9001:2015 certified for quality management systems for its compliance in the filling and sale of compressed refrigerant gases.
- The company has seen a consistent increase in revenue from operations. Revenue from operations increased from Rs 185.88 crore in FY22 to Rs 225.50 crore in FY23 to Rs 233.23 crore in FY24.
Tentative Date / Timetable
| Bid/Offer Opens On | Sep 22, 2026 |
| Bid/Offer Closes On | Sep 24, 2026 |
| Finalisation of Basis of Allotment | Sep 25, 2026 |
| Initiation of Refunds | Sep 28, 2026 |
| Credit of Shares to Demat Acct | Sep 28, 2026 |
| IPO Shares Listing Date | Sep 29, 2026 |
Company Promoters
| 1. | Rohit Asawa |
| 2. | Divya Asawa |
| 3. | Chanda Asawa and Rama Raju Penmatsas. |
Lead Managers
| 1. | Nirbhay Capital Services Pvt.Ltd. |
Contact Information
|
IPO Registrar
|
